Last reviewed · How we verify
Oxytocin ,Tranexamic acid and Ethamsylate
At a glance
| Generic name | Oxytocin ,Tranexamic acid and Ethamsylate |
|---|---|
| Also known as | Syntocinon , Kapron, Dicynon |
| Sponsor | Egymedicalpedia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Methods Decreasing Bleeding in Open Myomectomy (PHASE4)
- Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline) (NA)
- Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate (PHASE1, PHASE2)
- Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oxytocin ,Tranexamic acid and Ethamsylate CI brief — competitive landscape report
- Oxytocin ,Tranexamic acid and Ethamsylate updates RSS · CI watch RSS
- Egymedicalpedia portfolio CI